Skip to main content
ConductScienceScienceDex

Srinivas Raghavan Viswanathan

NIH Rank #3351
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12344771Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$1.9M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#3,351
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Srinivas Raghavan Viswanathan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Srinivas Raghavan Viswanathan as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA302918-01A1R01
    From biology to therapy: mechanism-informed targeting in translocation renal cell carcinoma
    Dana-Farber Cancer Institute
    $737.1K
    award amount
  • 5U01CA269505-04U01
    Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
    Dana-Farber Cancer Institute
    $507.1K
    award amount
  • 5R01CA279044-04R01
    Molecular mechanisms and therapeutic targeting of activated NRF2 signaling in MiT/TFE translocation renal cell carcinoma
    Dana-Farber Cancer Institute
    $495.7K
    award amount
  • 5R21CA296230-02R21
    Targeting the CDK4/6 pathway in MiT/TFE-translocation renal cell carcinoma
    Dana-Farber Cancer Institute
    $208K
    award amount

Award organization

Organizations that administered FY2026 awards listing Srinivas Raghavan Viswanathan as a PI.

FY2026 award administered by Dana-Farber Cancer Institute (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8911
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Entered Top 25% Nationally
    Ranked #3433
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Srinivas Raghavan Viswanathan.

Cheng-zhong Zhang
Dana-Farber Cancer Institute
2
shared awards
Eric L Smith
Dana-Farber Cancer Institute
1
shared award

Explore further

Find collaborators for Srinivas Raghavan Viswanathan

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →